| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |